These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

207 related items for PubMed ID: 2841084

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Recent developments in noradrenergic neurotransmission and its relevance to the mechanism of action of certain antihypertensive agents.
    Langer SZ, Cavero I, Massingham R.
    Hypertension; 1980; 2(4):372-82. PubMed ID: 6105128
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Cardiovascular effects and interaction with adrenoceptors of urapidil.
    van Zwieten PA, de Jonge A, Wilffert B, Timmermans PB, Beckeringh JJ, Thoolen MJ.
    Arch Int Pharmacodyn Ther; 1985 Aug; 276(2):180-201. PubMed ID: 4051641
    [Abstract] [Full Text] [Related]

  • 6. Pharmacology of centrally acting hypotensive drugs.
    van Zwieten PA.
    Br J Clin Pharmacol; 1980 Aug; 10 Suppl 1(Suppl 1):13S-20S. PubMed ID: 6104975
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Alpha-blocking potencies of antihypertensive agents (prazosin, terazosin, bunazosin, SGB-1534 and ketanserin) having with quinazoline or quinazolinedione as assessed by radioligand binding assay methods in rat brain.
    Tsuchihashi H, Nagatomo T.
    J Pharmacobiodyn; 1989 Mar; 12(3):170-4. PubMed ID: 2569512
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. The renaissance of centrally acting antihypertensive drugs.
    van Zwieten PA.
    J Hypertens Suppl; 1999 Aug; 17(3):S15-21. PubMed ID: 10489094
    [Abstract] [Full Text] [Related]

  • 11. The hypotensive activity and side effects of methyldopa, clonidine, and guanfacine.
    van Zwieten PA, Thoolen MJ, Timmermans PB.
    Hypertension; 1984 Aug; 6(5 Pt 2):II28-33. PubMed ID: 6094346
    [Abstract] [Full Text] [Related]

  • 12. The alpha 1- and alpha 2-adrenoceptor selectivity of drugs with potential effects on blood pressure--a radioligand-binding study.
    Offermeier J, van Rooyen JM, Rossouw J.
    S Afr Med J; 1986 Feb 15; 69(4):234-6. PubMed ID: 2869590
    [Abstract] [Full Text] [Related]

  • 13. Deviating central hypotensive activity of urapidil in the cat.
    van Zwieten PA, Mathy MJ, Thoolen MJ.
    J Pharm Pharmacol; 1985 Nov 15; 37(11):810-1. PubMed ID: 2867163
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Centrally acting antihypertensive drugs. Present and future.
    van Zwieten PA.
    Clin Exp Hypertens; 1999 Nov 15; 21(5-6):859-73. PubMed ID: 10423108
    [Abstract] [Full Text] [Related]

  • 19. Modulation of sympathetic outflow by centrally acting antihypertensive drugs.
    van Zwieten PA.
    Cardiovasc Drugs Ther; 1996 Jun 15; 10 Suppl 1():283-9. PubMed ID: 8827951
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.